INVASIVE PULMONARY ASPERGILLOSIS FOLLOWING BEVACIZUMAB TREATMENT FOR NON-SMALL CELL LUNG CANCER

INVASIVE PULMONARY ASPERGILLOSIS FOLLOWING BEVACIZUMAB TREATMENT FOR NON-SMALL CELL LUNG CANCER

Bevacizumab is a recombinant humanized monoclonal antibody targeting the vascular endothelial growth factor; it is actually approved for the treatment of unresectable, locally advanced and metastatic non-small cell lung cancer in association with chemotherapy and as maintenance therapy. Infection ri...

Full description

Bibliographic Details
Main Authors: Khadija Bellahammou, Asmaa Lakhdissi, Akkar Othman, Salmi Narimane, Ibrahim El Ghissassi, Fadoua Rais, Naoual Benhmidou, Hind M'rabti, Hassan Errihani
Format: Article
Language:English
Published: Bulgarian Association of Young Surgeons 2016-08-01
Series:International Journal of Surgery and Medicine
Subjects:
Invasive aspergillosis
Bevacizumab
Online Access:http://dx.doi.org/10.5455/ijsm.invasive-pulmonary-aspergillosis

Internet

http://dx.doi.org/10.5455/ijsm.invasive-pulmonary-aspergillosis

Similar Items